Skip to main content

Table 2 Environmental and clinical characteristics of the study population according to levels of asthma control

From: Factors associated with asthma control: MOSAR study (Multicenter Observational Study of Asthma in Rabat-Morocco)

  All Controlled Partly controlled Uncontrolled p-value
n = 396 n = 211 n = 72 n = 113  
Season of consultation, n(%)      .280
  Summer 69(17.5) 44(63.8) 10(14.5) 15(21.7)  
  Automn 129(32.7) 62(48.1) 26(20.2) 41(31.8)  
  Winter 155(39.3) 82(52.9) 25(16.1) 48(31.0)  
  Spring 41(10.4) 21(51.2) 11(26.8) 9(22.0)  
Reasons of the current visit, n(%)      .000*
  A follow-up visit 348(87.9) 208(59.8) 60(17.2) 80(23.0)  
  Aggravation of asthma 48(12.1) 3(6.2) 12(25.0) 33(68.8)  
 History of asthma, mean(±SD) 11.4(±9.7) 12(±9.9) 10(±9.5) 11(±9.5) .331
 Family history of asthma, n(%)      .514
  None 226(58.2) 115(50.9) 42(18.6) 69(30.5)  
  Yes (parents, grandparents, uncles and aunts) 162(41.8) 92(56.8) 26(16.0) 44(27.2)  
Smoking habits, n(%)      .031*
  Never smoker 327(83.4) 166(50.8) 57(17.4) 104(31.8)  
  Active smoker 35(8.9) 21(60.0) 9(25.7) 5(14.3)  
  Ex-smoker 30(7.7) 22(73.3) 4(13.3) 4(13.3)  
Passive smoking, n(%)      .881
  No 144(39.5) 77(53.3) 27(18.8) 40(27.8)  
  Yes 221(60.5) 120(54.3) 37(16.7) 64(29.0)  
Concomitant diseases, n(%)      .001*
  No 136(34.4) 89(65.4) 21(15.4) 26(19.1)  
  Yes 259(65.6) 121(46.7) 51(19.7) 87(33.6)  
Co-morbidities, n(%)      
  Rhinitis 221(59.7) 109(49.3) 44(19.9) 68(30.8) .045*
  Allergic conjunctivitis 165(44.6) 78(47.3) 34(20.6) 53(32.1) .039*
  Gastroesophageal Reflux Disease 38(9.6) 12(31.6) 8(21.1) 18(47.4) .011*
  Respiratory Infections 65(16.5) 13(20.0) 18(27.7) 34(52.3) .000*
Waking during the night, n(%)      .000*
  No 254(65.3) 205(80.7) 18(7.1) 31(12.2)  
  Yes 135(34.7) 0(0.0) 53(39.3) 82(60.7)  
Number of crisis, n(%)      .000*
  ≤2/week 276(70.6) 208(75.4) 55(19.9) 13(4.7)  
  > 2/week 115(29.4) 0(0.0) 16(13.9) 99(86.1)  
Symptoms during 3 previous months      
  Expectoration 29(7.3) 0(0.0) 7(24.1) 22(75.9) .000*
  Wheezing 92(72.4) 0(0.0) 36(39.1) 56(60.9) .016*
  Dyspnea 109(27.5) 0(0.0) 38(34.9) 71(65.1) .000*
  Nocturnal coughing 69(55.2) 0(0.0) 26(37.7) 43(62.3) .283
Allergy to, n(%)      
  Dust 295(76.8) 153(51.9) 56(19.0) 86(29.2) .199
  Animals 76(19.8) 29(38.2) 18(23.7) 29(38.2) .008*
  Mold 233(60.7) 123(52.8) 41(17.6) 69(29.6) .767
  Pollen 121(31.6) 57(47.1) 24(19.8) 40(33.1) .157
 Smoke 20(5.1) 9(45.0) 6(30.0) 5(25.0) .375
 Medication 40(10.1) 25(62.5) 3(7.5) 12(30.0) .168
 Certain foods 49(14.2) 25(51.0) 6(12.2) 18(36.7) .333
 Season variation 89(22.5) 50(56.2) 11(12.4) 28(31.5) .260
 Other cause of crisis, n(%)
  Stressful event 8(2.0) 4(50.0) 2(25.0) 2(25.0) .879
  Emotion 2(0.5) 0(0.0) 0(0.0) 2(100.0) .081
  Effort 16(4.1) 6(37.5) 3(18.8) 7(43.8) .348
Pulmonary function testing (FEV), n(%)      .377
  FEV < 80% 29(64.4) 16(55.2) 7(24.1) 6(20.7)  
  FEV ≥80% 16(35.6) 6(37.5) 7(43.8) 3(18.8)  
Adherence to treatment, n(%)      .488
  No 12(3.0) 6(50.0) 1(8.3) 5(41.7)  
  Yes 384(97.0) 205(53.4) 71(18.5) 108(28.1)  
  1. FEV Forced Expiratory Volume in one second, n number of cases, SD Standard Deviation;%: percentage
  2. Results are presented as mean ± SD or n(%) when appropriate
  3. * Significant, P < 0.05